SPC250
Patisíran
Status:
VeittApplication date:
13.2.2019Application published:
15.3.2019Grant published:
15.11.2021
Max expiry date:
28.8.2033Medicine name:
OnpattroMedicine for children:
No
Timeline
Today
13.2.2019Application
15.3.2019Publication
15.11.2021Registration
28.8.2033Expires
Marketing license
IS authorization number:
EU/1/18/1320/001Date:
24.9.2018
Foreign authorization number:
EU/1/18/1320Date:
27.8.2018
Owner
Name:
Alnylam Pharmaceuticals, Inc.Address:
300 Third Street, 3rd Floor, Cambridge US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2937418